3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
54
Lymphoma
44
Lymphoma, Large B-Cell, Diffuse
35
Lymphoma, Follicular
31
Precursor Cell Lymphoblastic Leukemia-Lymphoma
22
Lymphoma, Non-Hodgkin
22
Multiple Myeloma
19
Leukemia
17
Burkitt Lymphoma
13
Hodgkin Disease
12
Lymphoma, Mantle-Cell
10
Neoplasms
9
Lymphoma, Large-Cell, Immunoblastic
8
Lymphoma, B-Cell, Marginal Zone
8
Lymphoma, Large-Cell, Anaplastic
7
Neoplasms, Plasma Cell
6
Neoplasm Metastasis
6
Lymphoma, T-Cell, Peripheral
6
Recurrence
4
Leukemia, Lymphocytic, Chronic, B-Cell
4
Parkinson Disease 4, Autosomal Dominant Lewy Body
3
Pain
3
Lymphoma, B-Cell
3
Prostatic Neoplasms, Castration-Resistant
2
Prostate Cancer Metastatic
2
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
2
Myasthenia Gravis
2
Leukemia, Biphenotypic, Acute
2
Disease
2
Interventions
radium Ra 223 dichloride
1
niraparib
1
enzalutamide
1
darolutamide
1
capivasertib
1
cabazitaxel
1
apalutamide
1
abiraterone
1
Solutions
1
Prednisone
1
Injections
1
Docetaxel
1
Carboplatin
1
Abiraterone Acetate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Metastatic Castration-resistant Prostate Cancer (mCRPC)
×
Prednisone
×
Clear all
NCT03903835
2025-04-09
ProBio
Karolinska Institutet
Phase 3
Recruiting
750 enrolled